TY  - JOUR
T1  - MAking the case for selective use of statins in the primary prevention setting
AU  - Minder C, Blaha MJ, Tam LM, et al
Y1  - 2011/09/26
N1  - 10.1001/archinternmed.2011.349
JO  - Archives of Internal Medicine
SP  - 1593
EP  - 1594
VL  - 171
IS  - 17
N2  - 
We disagree that “less is more” when it comes to statins for primary prevention of cardiovascular disease (CVD). In accord with current National Cholesterol Education Program Adult Treatment Panel III (ATP III) guidelines, we believe there is compelling evidence to support the use of statins for primary prevention in patients at high risk (Framingham risk score, >10%) for developing coronary heart disease (CHD) over the next 10 years.2

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2011.349
UR  - http://dx.doi.org/10.1001/archinternmed.2011.349
ER  -